retatrutide approved Retatrutide, an experimental weight-loss drug, has not been by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide: Benefits, Mechanism & Research

One of the most promising treatments we offer is Semaglutide GLP-1, a glucagon-like peptide-1 (GLP-1) receptor agonist that has shown exceptional effectiveness in facilitating weight loss for overweight or obese adults

For patients preferring oral administration, PlexusDx offers GLP-Squared Oral starting at $369 per month, combining the convenience of tablet-based therapy with dual-compound efficacy

2015;100:E596E600

Visible weight changes are typically noted at 812 weeks of consistent use

Our Treatment Philosophy Weight management is similar to a chronic condition like high blood pressure, and should be treated as such, with medication accompanied by lifestyle changes